Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRINCIPLE: Prasugrel vs Clopidogrel in PCI
NCT00357968Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of prasugrel in coronary artery disease (CAD), sponsored by Eli Lilly and Company. Started Aug 2006; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00357968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357968.